Xencor Inc (XNCR) stock
XNCRNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 5/30194% above fair value
$34.39−0.11 (-0.32%)
Close on Nov 18, 2026Market cap $2.56BP/E –Yield –
Xencor operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Xencor's operating cash flow for the twelve months ending Jun 30, 2026 was -$205.81M. For fiscal 2025 it was -$135.12M. The highest annual figure on record is $95.24M in fiscal 2016.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$135.12M | – |
| FY2024 | Dec 31, 2024 | -$202.19M | – |
| FY2023 | Dec 31, 2023 | -$77.93M | -418.3% |
| FY2022 | Dec 31, 2022 | $24.49M | – |
| FY2021 | Dec 31, 2021 | -$16.85M | – |
| FY2020 | Dec 31, 2020 | -$5.00M | -107.8% |
| FY2019 | Dec 31, 2019 | $64.37M | – |
| FY2018 | Dec 31, 2018 | -$79.76M | – |
| FY2017 | Dec 31, 2017 | -$33.60M | -135.3% |
| FY2016 | Dec 31, 2016 | $95.24M | +257.2% |
| FY2015 | Dec 31, 2015 | $26.67M | – |
| FY2014 | Dec 31, 2014 | -$21.35M | – |
| FY2013 | Dec 31, 2013 | -$5.45M | – |
| FY2012 | Dec 31, 2012 | -$11.05M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$55.66M | – |
| Q1 FY2026 | Mar 31, 2026 | -$67.63M | – |
| Q4 FY2025 | Dec 31, 2025 | -$51.71M | – |
| Q3 FY2025 | Sep 30, 2025 | -$30.82M | – |
| Q2 FY2025 | Jun 30, 2025 | -$36.37M | – |
| Q1 FY2025 | Mar 31, 2025 | -$16.22M | – |
| Q4 FY2024 | Dec 31, 2024 | -$49.84M | -374.3% |
| Q3 FY2024 | Sep 30, 2024 | -$28.14M | – |
| Q2 FY2024 | Jun 30, 2024 | -$67.35M | – |
| Q1 FY2024 | Mar 31, 2024 | -$56.86M | – |
| Q4 FY2023 | Dec 31, 2023 | $18.17M | – |
| Q3 FY2023 | Sep 30, 2023 | -$27.28M | – |
| Q2 FY2023 | Jun 30, 2023 | -$38.20M | -186.3% |
| Q1 FY2023 | Mar 31, 2023 | -$30.61M | -626.5% |
| Q4 FY2022 | Dec 31, 2022 | -$24.43M | -139.5% |
| Q3 FY2022 | Sep 30, 2022 | -$1.17M | – |
| Q2 FY2022 | Jun 30, 2022 | $44.27M | – |
| Q1 FY2022 | Mar 31, 2022 | $5.82M | – |
| Q4 FY2021 | Dec 31, 2021 | $61.79M | +261.7% |
| Q3 FY2021 | Sep 30, 2021 | -$39.02M | – |
| Q2 FY2021 | Jun 30, 2021 | -$9.65M | – |
| Q1 FY2021 | Mar 31, 2021 | -$29.97M | -416.8% |
| Q4 FY2020 | Dec 31, 2020 | $17.08M | – |
| Q3 FY2020 | Sep 30, 2020 | -$3.87M | – |
| Q2 FY2020 | Jun 30, 2020 | -$27.68M | -125.4% |
| Q1 FY2020 | Mar 31, 2020 | $9.46M | – |
| Q4 FY2019 | Dec 31, 2019 | -$19.58M | – |
| Q3 FY2019 | Sep 30, 2019 | -$6.48M | – |
| Q2 FY2019 | Jun 30, 2019 | $109.16M | – |
| Q1 FY2019 | Mar 31, 2019 | -$18.73M | – |
| Q4 FY2018 | Dec 31, 2018 | -$16.78M | – |
| Q3 FY2018 | Sep 30, 2018 | -$10.31M | – |
| Q2 FY2018 | Jun 30, 2018 | -$28.42M | – |
| Q1 FY2018 | Mar 31, 2018 | -$24.25M | – |
| Q4 FY2017 | Dec 31, 2017 | -$6.67M | – |
| Q3 FY2017 | Sep 30, 2017 | -$3.51M | -102.6% |
| Q2 FY2017 | Jun 30, 2017 | -$12.88M | – |
| Q1 FY2017 | Mar 31, 2017 | -$10.55M | – |
| Q4 FY2016 | Dec 31, 2016 | -$15.17M | – |
| Q3 FY2016 | Sep 30, 2016 | $134.07M | – |
See a number that looks wrong?